1999
DOI: 10.1016/s0009-2797(99)00105-2
|View full text |Cite
|
Sign up to set email alerts
|

Induction of apoptosis by remoxipride metabolites in HL60 and CD34+/CD19− human bone marrow progenitor cells: potential relevance to remoxipride-induced aplastic anemia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
7
0

Year Published

2000
2000
2012
2012

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 13 publications
(9 citation statements)
references
References 21 publications
2
7
0
Order By: Relevance
“…These results allow rationalization of previous findings that only NCQ-344 had the ability to induce both apoptosis and necrosis (8). Necrosis may reflect the ability of the para-quinone of NCQ-344 to deplete GSH and/or modify critical protein thiol residues.…”
Section: Resultssupporting
confidence: 85%
“…These results allow rationalization of previous findings that only NCQ-344 had the ability to induce both apoptosis and necrosis (8). Necrosis may reflect the ability of the para-quinone of NCQ-344 to deplete GSH and/or modify critical protein thiol residues.…”
Section: Resultssupporting
confidence: 85%
“…To further confirm this finding, HL-60 cells were also treated with the hydroquinone and catechol metabolites (NCQ344 and NCQ436, respectively) of the antipsychotic drug remoxipride. These polyphenolic metabolites of remoxipride were selected for study since they are known to induce apoptosis in MPO-rich HL-60 cells, and remoxipride, like benzene, has been associated with induction of aplastic anemia ( , ). When HL-60 cells were treated with NCQ344, the percentage of cells with loss of MTP increased significantly from 13% (control cells) to 51% (Figure ).…”
Section: Resultsmentioning
confidence: 99%
“…Previous studies have used one or both of these cytotoxicity assays and/or the differential dye uptake assay in combination with other assay methods (Edwards and Tolkovsky, 1994;Hardwick et al;Hughes et al, 1996;Burger et al, 1999;Lizard et al, 1999;McGuinness et al, 1999;Sumitomo et al, 1999;DeMeester et al, 1997). However, none have used this specific combination of assays in evaluating apoptosis in breast cancer cell lines.…”
Section: Discussionmentioning
confidence: 99%